Oruka Therapeutics (ORKA) EBIT (QoQ) (2010 - 2024)
Oruka Therapeutics (ORKA) EBIT (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -25.79% |
| Mar 31, 2024 | -56.10% |
| Dec 31, 2023 | 17.91% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | -9.86% |
| Mar 31, 2023 | -16.02% |
| Dec 31, 2022 | 39.34% |
| Sep 30, 2022 | 20.72% |
| Jun 30, 2022 | 1.77% |
| Mar 31, 2022 | 42.31% |
| Dec 31, 2021 | -20.44% |
| Sep 30, 2021 | 2.50% |
| Jun 30, 2021 | -17.92% |
| Mar 31, 2021 | 19.98% |
| Dec 31, 2020 | -157.59% |
| Sep 30, 2020 | -51.91% |
| Jun 30, 2020 | 2.24% |
| Mar 31, 2020 | -4.85% |
| Dec 31, 2019 | -2.49% |
| Sep 30, 2019 | 17.31% |